Targeting cancer stem cells to suppress acquired chemotherapy resistance
2013 · Oncogene · 241 citations
https://doi.org/10.1038/onc.2013.411
J
Josep Domingo‐Domenech
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
3.4K
Citations
25
h-index
37
i10-index
Josep Domingo‐Domenech is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Prostate Cancer Treatment and Research & FOXO transcription factor regulation & Immunotherapy and Immune Responses. The author has an h-index of 25, co-authored 80 publications.
ORCID: 0000-0002-7870-7511Papers by this author
worksActivation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse
2005 · British Journal of Cancer · 113 citations
https://doi.org/10.1038/sj.bjc.6602851
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
2006 · Molecular Cancer Therapeutics · 106 citations
https://doi.org/10.1158/1535-7163.mct-05-0147
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer
2023 · Cell Reports Medicine · 27 citations
https://doi.org/10.1016/j.xcrm.2023.100937
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat